Cargando…

Magnetoliposomes containing magnesium ferrite nanoparticles as nanocarriers for the model drug curcumin

Magnesium ferrite nanoparticles, with diameters around 25 nm, were synthesized by coprecipitation method. The magnetic properties indicate a superparamagnetic behaviour, with a maximum magnetization of 16.2 emu g(−1), a coercive field of 22.1 Oe and a blocking temperature of 183.2 K. These MgFe(2)O(...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardoso, Beatriz D., Rio, Irina S. R., Rodrigues, Ana Rita O., Fernandes, Francisca C. T., Almeida, B. G., Pires, A., Pereira, A. M., Araújo, J. P., Castanheira, Elisabete M. S., Coutinho, Paulo J. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6227978/
https://www.ncbi.nlm.nih.gov/pubmed/30473847
http://dx.doi.org/10.1098/rsos.181017
Descripción
Sumario:Magnesium ferrite nanoparticles, with diameters around 25 nm, were synthesized by coprecipitation method. The magnetic properties indicate a superparamagnetic behaviour, with a maximum magnetization of 16.2 emu g(−1), a coercive field of 22.1 Oe and a blocking temperature of 183.2 K. These MgFe(2)O(4) nanoparticles were used to produce aqueous and solid magnetoliposomes, with sizes below 130 nm. The potential drug curcumin was successfully incorporated in these nanosystems, with high encapsulation efficiencies (above 89%). Interaction by fusion between both types of drug-loaded magnetoliposomes (with or without PEGylation) and models of biological membranes was demonstrated, using FRET or fluorescence quenching assays. These results point to future applications of magnetoliposomes containing MgFe(2)O(4) nanoparticles in cancer therapy, allowing combined magnetic hyperthermia and chemotherapy.